[go: up one dir, main page]

DE3786870D1 - Methode zur herstellung von proteinen. - Google Patents

Methode zur herstellung von proteinen.

Info

Publication number
DE3786870D1
DE3786870D1 DE8787115016T DE3786870T DE3786870D1 DE 3786870 D1 DE3786870 D1 DE 3786870D1 DE 8787115016 T DE8787115016 T DE 8787115016T DE 3786870 T DE3786870 T DE 3786870T DE 3786870 D1 DE3786870 D1 DE 3786870D1
Authority
DE
Germany
Prior art keywords
producing proteins
proteins
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787115016T
Other languages
English (en)
Other versions
DE3786870T2 (de
Inventor
Hiroshi Teraoka
Masaru Shin
Osamu Ohara
Norihisa Kikuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of DE3786870D1 publication Critical patent/DE3786870D1/de
Publication of DE3786870T2 publication Critical patent/DE3786870T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8135—Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE87115016T 1986-10-14 1987-10-14 Methode zur Herstellung von Proteinen. Expired - Fee Related DE3786870T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24504886 1986-10-14
JP31460386 1986-12-23

Publications (2)

Publication Number Publication Date
DE3786870D1 true DE3786870D1 (de) 1993-09-09
DE3786870T2 DE3786870T2 (de) 1993-11-11

Family

ID=26537027

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87115016T Expired - Fee Related DE3786870T2 (de) 1986-10-14 1987-10-14 Methode zur Herstellung von Proteinen.

Country Status (6)

Country Link
EP (1) EP0264118B1 (de)
KR (1) KR960013466B1 (de)
AU (1) AU603145B2 (de)
CA (1) CA1339736C (de)
DE (1) DE3786870T2 (de)
ES (1) ES2059340T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0616716B2 (ja) * 1986-10-14 1994-03-09 塩野義製薬株式会社 酵母におけるヒトｐｓｔｉの製造法
WO1988003171A1 (en) * 1986-10-30 1988-05-05 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
NZ224663A (en) * 1987-05-28 1990-11-27 Amrad Corp Ltd Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors
JPS6427473A (en) * 1987-07-23 1989-01-30 Mochida Pharm Co Ltd Human pancreas-secreting trypsin inhibitor and production thereof
JPH07102137B2 (ja) * 1988-07-19 1995-11-08 塩野義製薬株式会社 修飾ヒトｐｓｔｉ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094506B1 (de) * 1982-04-15 1988-10-12 Merck & Co. Inc. DNS Klonierungsvektor TG1, Derivate, Produkte und Verfahren
DE3587730T2 (de) * 1984-02-08 1994-05-05 Cetus Oncology Corp Kontrollsysteme für rekombinant-manipulationen.
JPH0616716B2 (ja) * 1986-10-14 1994-03-09 塩野義製薬株式会社 酵母におけるヒトｐｓｔｉの製造法
WO1988003171A1 (en) * 1986-10-30 1988-05-05 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same

Also Published As

Publication number Publication date
AU603145B2 (en) 1990-11-08
DE3786870T2 (de) 1993-11-11
KR960013466B1 (ko) 1996-10-05
AU7976587A (en) 1988-04-21
EP0264118A3 (en) 1988-12-14
ES2059340T3 (es) 1994-11-16
CA1339736C (en) 1998-03-17
EP0264118A2 (de) 1988-04-20
EP0264118B1 (de) 1993-08-04
KR880005263A (ko) 1988-06-28

Similar Documents

Publication Publication Date Title
DE3774592D1 (de) Methode zur herstellung von schuppenaehnlichem gut.
DE3669310D1 (de) Verfahren zur herstellung von cycloolefinen.
DE3762745D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylthiazol.
DE3763558D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylpyridin.
DE3675327D1 (de) Verfahren zur herstellung von 5-aethyliden-2-norbornen.
DE3767680D1 (de) Methode zur herstellung von adiponitril.
DE3773889D1 (de) Verfahren zur herstellung von merkaptomethylphenolen.
DE3668316D1 (de) Verfahren zur herstellung von cycloolefinen.
DE3780704D1 (de) Verfahren zur herstellung von n-acyltetrahydroisochinoline.
DE3781660D1 (de) Verfahren zur herstellung von elementen mit zwischenraum.
DE3777692D1 (de) Verfahren zur herstellung von makromeren.
DE3675860D1 (de) Verfahren zur herstellung von pyromellitsaeuredianhydrid.
DE3786870D1 (de) Methode zur herstellung von proteinen.
DE3766910D1 (de) Verfahren zur herstellung von dihydrocyclocitral.
DE3769076D1 (de) Verfahren zur herstellung von fluorbenzaldehyden.
DE3768372D1 (de) Verfahren zur herstellung von aethylenoxid.
DE3670075D1 (de) Verfahren zur herstellung von bis-hydroxyphenyl-n-alkanen.
DE3769263D1 (de) Verfahren zur herstellung von bromfluoroethylhypofluorit.
DE3777475D1 (de) Verfahren zur herstellung von polyphenylen-ether-polyester-copolymeren.
DE3765888D1 (de) Verfahren zur herstellung von l-dopa.
ATA304487A (de) Verfahren zur herstellung von 9alpha-hydroxy-4-androsten-3,17-dion
DE3667796D1 (de) Verfahren zur herstellung von menachinon-4.
DE3675817D1 (de) Verfahren zur herstellung von 2-perfluorpropoxy-perfluorpropionylfluorid.
DE3675866D1 (de) Methode zur herstellung von diphenylmethandicarbamidsaeureestern.
DE3767948D1 (de) Verfahren zur herstellung von tertiaeren alkylphosphanen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee